V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 90005119 | 90002679 | 1.59 | null | null | null | 2016-07-21 | A-PREDICT TRIAL | N | 0 | 90040525 | STAR TRIAL |
| 210020131 | 210011566 | null | 64.9 | Curative (C) | 2013-07-13 | 2013-08-04 | Temozolomide + RT | null | 0 | 210030138 | TEMOZOLOMIDE + RT |
| 90007667 | 90008176 | 1.7 | 76.4 | Palliative (P) | 2016-05-23 | 2017-03-13 | NIVOLUMAB | 02 | 0 | 90031830 | NIVOLUMAB |
| 90007693 | 90005071 | null | 79 | Palliative (P) | 2016-10-27 | 2016-11-01 | NIVOLUMAB | N | 0 | 90032220 | NIVOLUMAB |
| 90007844 | 90005200 | 1.94 | 63 | Palliative (P) | 2017-11-27 | 2017-11-27 | CABOZANTINIB | 2 | 0 | 90034779 | CABOZANTINIB |
| 90007929 | 90005264 | 1.55 | 0 | Palliative (P) | 2015-05-02 | 2015-06-21 | CABOZANTINIB | N | 0 | 90035973 | CABOZANTINIB |
| 90009422 | 90008054 | 1.5 | 64.8 | Palliative (P) | 2014-07-30 | 2016-04-11 | NIVOLUMAB | 02 | 0 | 90027108 | NIVOLUMAB |
| 90009464 | 90004871 | 1.77 | 88 | Palliative (P) | 2017-07-01 | 2017-07-01 | NIVOLUMAB | 2 | 0 | 90028579 | NIVOLUMAB |
| 90009516 | 90004949 | null | 125.9 | Curative (C) | 2017-03-30 | 2017-04-05 | Trial Unspecified | N | 0 | 90030029 | TRIAL |
| 90009532 | 90004985 | 1.78 | 63.3 | Palliative (P) | 2018-05-15 | 2018-05-22 | NIVOLUMAB | 2 | 0 | 90030421 | NIVOLUMAB |
| 90009624 | 90005184 | 1.7 | 67.6 | Palliative (P) | 2013-07-14 | 2016-12-16 | NIVOLUMAB | N | 0 | 90034517 | NIVOLUMAB |
| 90009881 | 90005720 | null | 55.9 | Palliative (P) | 2018-05-12 | 2018-05-16 | Cisplatin + Gemcitabine (D 1 & 8) | Y | 0 | 90022357 | CAPECITABINE + CISPLATIN |
| 90010329 | 90007927 | 1.64 | 102.6 | Palliative (P) | 2018-08-28 | 2018-09-18 | NIVOLUMAB | 01 | 0 | 90022856 | NIVOLUMAB |
| 90005192 | 90007099 | 1.6 | 80 | Disease modification (D) | 2016-03-19 | 2017-03-14 | Cisplatin + Pemetrexed | N | 0 | 90041104 | CISPLATIN + GEMCITABINE |
| 210005698 | 210001982 | 1.6 | 68.6 | Palliative (P) | null | 2014-11-28 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | 0 | 210017546 | FCR |
| 210026690 | 210011237 | 1.72 | 91.9 | Curative (C) | 2017-08-27 | 2017-10-09 | Trial Unspecified | 02 | 0 | 210028874 | TRIAL |
| 210007157 | 210002439 | null | 89 | Palliative (P) | 2015-03-04 | 2015-04-05 | FCR | N | 0 | 210022063 | FCR |
| 210008535 | 210002765 | null | 5.3 | Curative (C) | null | 2013-05-14 | ALL UKALL2011 Maintenance C4 | 1 | 0 | 210026606 | NOT MATCHED |
| 210008567 | 210002776 | null | 94.6 | Curative (C) | null | 2016-10-05 | CNS Medbl HR Cisplatin/Vinc/Cyclophos/GCSF | N | 0 | 210026724 | NOT MATCHED |
| 210008710 | 210002805 | 0 | null | Curative (C) | 2013-06-01 | 2013-07-14 | CNS PNET III Vinc, Cyclo, Etoposide | 1 | 0 | 210027215 | NOT MATCHED |
| 210008944 | 210002869 | null | null | Curative (C) | 2018-06-29 | 2018-06-30 | BMT | N | 0 | 210027964 | NOT MATCHED |
| 210009207 | 210034043 | 1.69 | 15.8 | Curative (C) | 2015-05-12 | 2015-05-26 | null | N | 0 | 210028775 | NOT MATCHED |
| 210009376 | 210034049 | 1 | null | Curative (C) | 2017-11-18 | 2017-12-01 | ALL UKALL2011 Maintenance B1 | 1 | 0 | 210029272 | UKALL 2011 |
| 210005775 | 210002006 | 1.66 | 88.4 | Disease modification (D) | 2015-08-02 | 2015-08-14 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | 0 | 210017812 | FCR |
| 210009485 | 210035421 | null | 42.4 | Curative (C) | 2014-08-02 | 2014-08-10 | CNS Ependy II VEC | N | 0 | 210029599 | NOT MATCHED |
| 210009521 | 210029026 | 0 | null | Curative (C) | 2014-06-27 | 2014-07-01 | ALL UKALL 2011 Trial | 01 | 0 | 210029731 | UKALL 2011 |
| 210009697 | 210029039 | null | null | Curative (C) | 2015-02-20 | 2015-02-24 | ALL UKALL2011 Ind A Sht Dex (PAsp) | Y | 0 | 210030262 | UKALL 2011 |
| 210009898 | 210037964 | 1.73 | 83.2 | Curative (C) | 2017-02-13 | 2017-02-14 | UKALL14- Ph 1 Induction | 02 | 0 | 210030925 | UKALL2014 |
| 210010027 | 210037094 | 1.68 | 72 | Palliative (P) | 2017-10-20 | 2017-10-20 | Rituximab | 02 | 0 | 210031316 | RITUXIMAB |
| 210010346 | 210024309 | 1.68 | 91.4 | Curative (C) | 2017-02-08 | 2017-02-08 | UKALL14- Ph 1 Induction | 01 | 0 | 210032357 | UKALL2014 |
| 210012409 | 210003739 | 0 | 0 | Palliative (P) | 2018-08-18 | 2018-08-19 | RIALTO TRIAL | 01 | 0 | 210039106 | RIALTO TRIAL |
| 210012533 | 210003776 | null | null | null | 2014-02-15 | 2014-02-17 | CNS LGG 2004 03 vinc weekly+ carbo | 1 | 0 | 210039491 | CARBOPLATIN + VINCRISTINE |
| 210013198 | 210003990 | 0 | 69 | Palliative (P) | null | 2016-05-12 | Abiraterone | null | 0 | 210041621 | LOMUSTINE + PROCARBAZINE + VINCRISTINE |
| 210018653 | 210010059 | 1.89 | 91.2 | Curative (C) | 2016-10-07 | 2016-10-07 | UKALL14- Ph 1 Induction | Y | 0 | 210020885 | UKALL2014 |
| 210019012 | 210010443 | 0 | 16.3 | Curative (C) | 2014-10-07 | 2014-10-11 | CYTARABINE + MERCAPTOPURINE + METHOTREXATE + PEGASPARAGINASE + VINCRISTINE | 02 | 0 | 210022960 | NOT MATCHED |
| 210020059 | 210011487 | 1.67 | 13.9 | Curative (C) | 2014-11-08 | 2014-11-19 | ESPHALL TRIAL | Y | 0 | 210029795 | TRIAL |
| 210020072 | 210011500 | 1.72 | 96.3 | Palliative (P) | 2014-11-28 | 2014-12-28 | Temozolomide + RT | N | 0 | 210029842 | TEMOZOLOMIDE + RT |
| 210020078 | 210027434 | 0.98 | 15.9 | Adjuvant (A) | 2015-03-06 | 2015-04-25 | Trial Unspecified | N | 0 | 210029868 | TRIAL |
| 210009482 | 210035421 | null | 17 | Curative (C) | 2013-09-22 | 2013-09-23 | ALL UKALL2011 TRIAL | Y | 0 | 210029599 | UKALL 2011 |
| 210024672 | 210007479 | 1.7 | null | Curative (C) | 2017-06-20 | 2017-06-28 | ALL UKALL2011 Maintenance C2 | 01 | 0 | 210013321 | UKALL2011 |
| 210025966 | 210010189 | 1.66 | 6.6 | Disease modification (D) | 2017-08-11 | 2017-11-23 | CNS Headstart II Myeloablation | N | 0 | 210021334 | NOT MATCHED |
| 210026447 | 210010785 | 1.75 | null | Adjuvant (A) | 2013-09-08 | 2013-09-30 | Temozolomide + RT | N | 0 | 210026935 | TEMOZOLOMIDE + RT |
| 210035889 | 210008958 | 1.73 | 75.4 | Curative (C) | null | 2017-11-07 | Trial Unspecified | Y | 0 | 210017073 | TRIAL |
| 210028037 | 210013683 | 0 | null | Curative (C) | 2018-11-11 | 2018-11-16 | IVE-R | N | 0 | 210008519 | TAMIGA TRIAL |
| 210030565 | 210010697 | null | 64.5 | Curative (C) | null | 2016-02-19 | Temozolomide + RT | N | 0 | 210025775 | TEMOZOLOMIDE + RT |
| 210034485 | 210008330 | null | 57.7 | Curative (C) | 2014-11-19 | 2014-11-19 | UKALL14- Maintenance | Y | 0 | 210015220 | UKALL2014 |
| 210035732 | 210007998 | 1.83 | 89.7 | Palliative (P) | 2018-02-23 | 2018-04-04 | UKALL14- Ph 2 Induction | Y | 0 | 210014497 | UKALL2014 |
| 210035813 | 210008552 | 1.05 | 16.75 | Curative (C) | 2017-09-03 | 2017-09-03 | CNS PNET 5 Medbl L/StRsk Mnt B | 99 | 0 | 210015695 | NOT MATCHED |
| 210035884 | 210008941 | 1.54 | 0 | Curative (C) | 2017-12-11 | 2017-12-12 | Trial Unspecified | Y | 0 | 210017005 | TRIAL |
| 90011238 | 90003895 | 1.73 | 99.8 | Palliative (P) | 2016-09-17 | 2017-07-07 | NIVOLUMAB | 2 | 0 | 90014010 | NIVOLUMAB |